feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    S. Karger AG ; 1992
    In:  Transfusion Medicine and Hemotherapy Vol. 19, No. 3 ( 1992), p. 141-144
    In: Transfusion Medicine and Hemotherapy, S. Karger AG, Vol. 19, No. 3 ( 1992), p. 141-144
    Abstract: In a paired study 12 platelet concentrates (PC) of Fresenius AS-104 cell separator were stored in new polyolefin bags of Fresenius (LE 2) and Fenwal PL-732 bags. On day 0 and after 3 and 5 days of storage pH, pO 〈 sub 〉 2 〈 /sub 〉 , pCO 〈 sub 〉 2 〈 /sub 〉 , cell counts, platelet morphology and aggregability, plasma glucose, lactate, LDH and βTG were determined. The overall changes fell within the expected range. No relevant differences between the two bags could be detected, although a few parameters (pH, pCO 〈 sub 〉 2 〈 /sub 〉 ) are slightly but statistically/significantly different. It can be concluded that the new polyolefin bag is well suited for 5-day storage of PC’s from the AS-104.
    Type of Medium: Online Resource
    ISSN: 1660-3796 , 1660-3818
    Language: English
    Publisher: S. Karger AG
    Publication Date: 1992
    detail.hit.zdb_id: 2100533-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    In: Neonatology, S. Karger AG, Vol. 118, No. 4 ( 2021), p. 505-508
    Abstract: Current evidence from the COVID-19 pandemic suggests that neonatal SARS-coronavirus-2 infections usually have a mild course. Data on how maternal infection during pregnancy affects fetal development are scarce. We present the unique case of a moderate preterm infant with intracranial bleeding and periventricular leukomalacia as a potential consequence of post-COVID-19 hyperinflammation during pregnancy.
    Type of Medium: Online Resource
    ISSN: 1661-7800 , 1661-7819
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2021
    detail.hit.zdb_id: 2403535-X
    SSG: 12
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    S. Karger AG ; 1925
    In:  Gynecologic and Obstetric Investigation Vol. 69, No. 1-2 ( 1925), p. 104-112
    In: Gynecologic and Obstetric Investigation, S. Karger AG, Vol. 69, No. 1-2 ( 1925), p. 104-112
    Type of Medium: Online Resource
    ISSN: 0378-7346 , 1423-002X
    RVK:
    Language: English
    Publisher: S. Karger AG
    Publication Date: 1925
    detail.hit.zdb_id: 1482695-1
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    In: Digestion, S. Karger AG, Vol. 94, No. 3 ( 2016), p. 129-137
    Abstract: 〈 b 〉 〈 i 〉 Background/Aims: 〈 /i 〉 〈 /b 〉 This study is aimed at analyzing the survival rates and prognostic factors of stage IV colorectal cancer patients from 3 European cohorts undergoing combination chemotherapy with bevacizumab. 〈 b 〉 〈 i 〉 Methods: 〈 /i 〉 〈 /b 〉 Progression free-survival (PFS) and overall survival (OS) were analyzed in 172 patients using the Kaplan-Meier method and uni- and multivariable Cox proportional hazards regression models. 〈 b 〉 〈 i 〉 Results: 〈 /i 〉 〈 /b 〉 The median PFS was 9.7 and the median OS 27.4 months. Patients treated at centers in Germany (n = 97), Ireland (n = 32), and The Netherlands (n = 43) showed a median PFS of 9.9, 9.2, and 9.7 months, OS of 34.0, 20.5, and 25.1 months, respectively. Patients 〉 65 years had a significantly shorter PFS (9.5 vs. 9.8 months) but not OS (27.4 vs. 27.5 months) than younger patients. High tumor grade (G3/4) was associated with a shorter PFS, T4 classification with both shorter PFS and OS. Fluoropyrimidine (FP) chemotherapy backbones (doublets and single) had comparable outcomes, while patients not receiving FP backbones had a shorter PFS. In multivariable analysis, age and non-FP backbone were associated with inferior PFS, T4 classification and therapy line 〉 2nd were significantly associated with poor PFS and OS. 〈 b 〉 〈 i 〉 Conclusion: 〈 /i 〉 〈 /b 〉 The observed survival rates confirm previous studies and demonstrate reproducible benefits of combination bevacizumab regimens. Classification T4, non-FP chemotherapy backbone, and age 〉 65 were associated with inferior outcome.
    Type of Medium: Online Resource
    ISSN: 0012-2823 , 1421-9867
    RVK:
    RVK:
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2016
    detail.hit.zdb_id: 1482218-0
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    S. Karger AG ; 2021
    In:  Neonatology Vol. 118, No. 6 ( 2021), p. 734-735
    In: Neonatology, S. Karger AG, Vol. 118, No. 6 ( 2021), p. 734-735
    Type of Medium: Online Resource
    ISSN: 1661-7800 , 1661-7819
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2021
    detail.hit.zdb_id: 2403535-X
    SSG: 12
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    S. Karger AG ; 2014
    In:  Gastrointestinal Tumors Vol. 1, No. 4 ( 2014), p. 180-194
    In: Gastrointestinal Tumors, S. Karger AG, Vol. 1, No. 4 ( 2014), p. 180-194
    Abstract: 〈 b 〉 〈 i 〉 Background: 〈 /i 〉 〈 /b 〉 Gastric cancer is the second most common cause of cancer-related deaths worldwide. There are large geographic variations in the incidence of these tumors, with 60% occurring in East Asia. For patients with resectable disease, surgery and perioperative treatment can be effective. For patients with advanced gastric cancer, chemotherapy regimens result in a median survival of 9-11 months. In general, the prognosis for advanced disease is poor and 5-year overall survival rates are around 15%. Combination therapies yield better survival rates, albeit with increased toxicity. Therefore, more effective and less toxic treatment regimens are needed. 〈 b 〉 〈 i 〉 Summary: 〈 /i 〉 〈 /b 〉 The molecular aberrations that characterize the different subgroups of gastric cancer have been used as therapeutic targets. However, the heterogeneity and complexity of gastric cancers is a major challenge for the development of effective targeted therapies. This review examines the main molecular targets in the treatment of gastric cancer, namely the vascular endothelial growth factor (VEGF), human epidermal growth factor receptor 2 (HER2), hepatocyte growth factor (HGF)/c-Met, epidermal growth factor receptor (EGFR) and phosphoinositide 3-kinase (PI3K)/Akt pathways. 〈 b 〉 〈 i 〉 Key Message: 〈 /i 〉 〈 /b 〉 The molecular aberrations characteristic of gastric cancer are being explored for the development of targeted therapies, including the VEGF, HER2, HGF/c-Met, EGFR and PI3K/Akt signaling pathways. 〈 b 〉 〈 i 〉 Practical Implications: 〈 /i 〉 〈 /b 〉 Trastuzumab, an antibody which targets HER2, is the first approved targeted therapy for the treatment of gastric cancer. However, trastuzumab is only effective in HER2-positive tumors (about 10-20% of all gastric cancers). Ramucirumab, which targets the VEGF receptor 2, has yielded benefits with respect to overall survival in a phase III trial and is an effective treatment for advanced gastric cancer with approval in second-line treatment. Apatinib and rilotumumab are another two promising new agents currently under development.
    Type of Medium: Online Resource
    ISSN: 2296-3774 , 2296-3766
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2014
    detail.hit.zdb_id: 2735769-7
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    In: Neonatology, S. Karger AG, Vol. 103, No. 3 ( 2013), p. 199-204
    Abstract: 〈 b 〉 〈 i 〉 Objective: 〈 /i 〉 〈 /b 〉 Intrauterine growth restriction (IUGR) is a well-known cause of adverse neonatal outcomes. As it may have an impact on innate immune responses, we aimed to investigate several parameters of the innate immune response in preterm infants of ≤32 weeks gestation who were small for gestational age (SGA). 〈 b 〉 〈 i 〉 Methods: 〈 /i 〉 〈 /b 〉 We compared clinical data of SGA (n = 20) and appropriate for gestational age (AGA; n = 124) newborns with a gestational age of ≤32 weeks. We investigated full blood counts at birth and on days 3 and 7 of life and cytokine immune responses in a human whole cord blood assay. 〈 b 〉 〈 i 〉 Results: 〈 /i 〉 〈 /b 〉 SGA preterm infants had a higher risk of the combined outcome mortality or bronchopulmonary dysplasia. Numbers of white blood cells and neutrophils were diminished in SGA infants at birth and on day 3. At birth, platelet counts were also diminished while the number of nucleated red blood cells tended to be elevated in SGA infants. After stimulation of whole blood cell cultures with lipopolysaccharides, the concentrations of interleukin-6 and interleukin-10 were significantly lower in SGA preterm infants compared to AGA infants. 〈 b 〉 〈 i 〉 Conclusions: 〈 /i 〉 〈 /b 〉 SGA infants differ remarkably from AGA infants in full blood counts and in their ability to mount an immune response. Whether the quantitative deficiency in innate immunity plays a role for adverse outcomes needs to be investigated in larger future trials.
    Type of Medium: Online Resource
    ISSN: 1661-7800 , 1661-7819
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2013
    detail.hit.zdb_id: 2403535-X
    SSG: 12
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    In: Neonatology, S. Karger AG, Vol. 91, No. 1 ( 2007), p. 54-60
    Abstract: 〈 i 〉 Background: 〈 /i 〉 Vitamin C (ascorbic acid) is an essential water-soluble antioxidant in cells and plasma. Besides metabolic functions, vitamin C is also known to contribute to immune homeostasis. Recently, it has been demonstrated that vitamin C has an inhibitory effect on the expression of pro-inflammatory cytokines such as interleukin (IL)-6 and tumor necrosis factor alpha (TNF-α) in adult whole blood cells in vitro. It has been postulated that vitamin C might be an interesting compound for modulation of an over-exuberant immune response, e.g., in patient cohorts susceptible for the development of systemic inflammatory response syndrome such as neonates. It was the aim of this study to investigate the modulatory effects of vitamin C on the production of inflammatory mediators in neonatal cord blood cells. 〈 i 〉 Methods: 〈 /i 〉 The intracytoplasmic production of pro-inflammatory cytokines in neonatal cord blood cells stimulated with lipopolysaccharide or phorbol 12-myristate 13-acetate/ionomycin was assessed by flow-cytometry. 〈 i 〉 Results: 〈 /i 〉 In contrast to our previous observations from adult whole blood cells, 20 m 〈 i 〉 M 〈 /i 〉 vitamin C mildly stimulated the percentage of neonatal monocytes producing IL-6 after lipopolysaccharide stimulation (e.g., 11.3% increase compared to control, p = 0.005). In the presence of 20 m 〈 i 〉 M 〈 /i 〉 vitamin C, even a stronger stimulatory effect was noted for the percentage of IL-8 (e.g., 46.7% increase, p 〈 0.001) and TNF-α producing neonatal monocytes (e.g., 69.2% increase, p = 0.004; n = 20). In accordance with adult data, the percentage of neonatal lymphocytes producing IL-2 after phorbol 12-myristate 13-acetate/ionomycin stimulation was dose-dependently reduced (e.g., 41.3% inhibition, p = 0.001, 20 m 〈 i 〉 M 〈 /i 〉 vitamin C), while the percentage of TNF-α producing lymphocytes was mildly stimulated (e.g., 20.8% increase, p = 0.003, 20 m 〈 i 〉 M 〈 /i 〉 vitamin C). 〈 i 〉 Conclusions: 〈 /i 〉 Interestingly, vitamin C was demonstrated to enhance pro-inflammatory responses in CD14 〈 sup 〉 + 〈 /sup 〉 cord blood cells while only intracellular IL-2 production in CD3 〈 sup 〉 + 〈 /sup 〉 cells was diminished. These data suggest that vitamin C differentially influences intracytoplasmic cytokine production in adults and neonates, and further studies are needed to elucidate the underlying mechanisms of this selective immunomodulation.
    Type of Medium: Online Resource
    ISSN: 1661-7800 , 1661-7819
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2007
    detail.hit.zdb_id: 2403535-X
    SSG: 12
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    In: Neonatology, S. Karger AG, Vol. 117, No. 6 ( 2020), p. 665-672
    Abstract: 〈 i 〉 Ureaplasma 〈 /i 〉 species (spp.) are commonly regarded as low-virulence colonizers of the genitourinary tract. Intrauterine 〈 i 〉 Ureaplasma 〈 /i 〉 infection, however, has been associated with chorioamnionitis and preterm birth. The overall impact of a neonatal 〈 i 〉 Ureaplasma 〈 /i 〉 colonization is yet to be understood. High pathogen prevalence and frequent neurological morbidities particularly in immature preterm infants call for an assessment of the significance of 〈 i 〉 Ureaplasma 〈 /i 〉 spp. in neonatal neuroinflammation. This narrative review summarizes clinical data, animal studies, and 〈 i 〉 in vitro 〈 /i 〉 results to elucidate potential 〈 i 〉 Ureaplasma 〈 /i 〉 -associated neurological morbidities as well as underlying mechanisms. Increasing evidence indicates an involvement of 〈 i 〉 Ureaplasma 〈 /i 〉 spp. in invasive central nervous system infections, suggesting a meticulous ability of 〈 i 〉 Ureaplasma 〈 /i 〉 spp. to interfere with immune defense mechanisms. Ultimately, 〈 i 〉 Ureaplasma 〈 /i 〉 spp. should be considered as relevant pathogens in neonatal neuroinflammation.
    Type of Medium: Online Resource
    ISSN: 1661-7800 , 1661-7819
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2020
    detail.hit.zdb_id: 2403535-X
    SSG: 12
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    In: Neonatology, S. Karger AG, Vol. 119, No. 6 ( 2022), p. 695-702
    Abstract: 〈 b 〉 〈 i 〉 Introduction: 〈 /i 〉 〈 /b 〉 Sepsis is regarded as a risk factor for brain injury in preterm infants. We herein hypothesize that extremely low birth weight infants (ELBWI, birth weight & #x3c;1,000 g) having survived recurrent blood culture-proven late-onset sepsis (LOS) episodes are more likely to have an adverse long-term neurologic outcome. 〈 b 〉 〈 i 〉 Methods: 〈 /i 〉 〈 /b 〉 In a large multicenter observational study of ELBWI ≤28 6/7 weeks, we evaluated the impact of recurrent LOS (blood culture-proven, after day 7 of life) on development at 5–6 years. Neurodevelopment, behavior, and motor qualities were tested by blinded investigators. Univariate and logistic regression analyses were performed. 〈 b 〉 〈 i 〉 Results: 〈 /i 〉 〈 /b 〉 The cohort consisted of 1343 ELBWI including 1,080 infants without LOS, 186 infants with one LOS, and 77 with recurrent LOS, i.e., 55 infants with two and 22 infants with three LOS episodes. After Bonferroni-Holm correction, multiple logistic regression analysis revealed recurrent sepsis to be significantly associated with adverse motor development (critical MABC-2 testing: 3.3 [1.5–7.3], 〈 i 〉 p 〈 /i 〉 = 0.003, 〈 i 〉 p 〈 /i 〉 〈 sub 〉 B 〈 /sub 〉 = 0.012), whereas no significant impact of recurrent LOS was found on intelligence quotient and behavioral difficulties. Odds of having critical motor testing results for infants with recurrent LOS were 1.7 times (95% confidence interval 1.4–2.3) that of infants with one LOS. 〈 b 〉 〈 i 〉 Conclusion: 〈 /i 〉 〈 /b 〉 Recurrent sepsis in preterm infants is associated with adverse long-term motor development. However, infants with recurrent infections are also more likely to have preterm-related complications, and reasons for a worse neurodevelopmental outcome remain to be elucidated.
    Type of Medium: Online Resource
    ISSN: 1661-7800 , 1661-7819
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2022
    detail.hit.zdb_id: 2403535-X
    SSG: 12
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages